Ensysce Biosciences (ENSC) Total Non-Current Liabilities (2021 - 2025)
Historic Total Non-Current Liabilities for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to $35.0.
- Ensysce Biosciences' Total Non-Current Liabilities fell 9891.07% to $35.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0, marking a year-over-year decrease of 9891.07%. This contributed to the annual value of $10096.0 for FY2024, which is 6174.02% down from last year.
- Latest data reveals that Ensysce Biosciences reported Total Non-Current Liabilities of $35.0 as of Q3 2025, which was down 9891.07% from $1033.0 recorded in Q2 2025.
- Ensysce Biosciences' 5-year Total Non-Current Liabilities high stood at $8.4 million for Q2 2022, and its period low was $35.0 during Q3 2025.
- Over the past 5 years, Ensysce Biosciences' median Total Non-Current Liabilities value was $91318.0 (recorded in 2023), while the average stood at $1.7 million.
- Per our database at Business Quant, Ensysce Biosciences' Total Non-Current Liabilities crashed by 878.23% in 2022 and then tumbled by 9891.24% in 2023.
- Quarter analysis of 5 years shows Ensysce Biosciences' Total Non-Current Liabilities stood at $8.1 million in 2021, then crashed by 94.43% to $450494.0 in 2022, then crashed by 94.14% to $26388.0 in 2023, then crashed by 61.74% to $10096.0 in 2024, then crashed by 99.65% to $35.0 in 2025.
- Its Total Non-Current Liabilities stands at $35.0 for Q3 2025, versus $1033.0 for Q2 2025 and $130180.0 for Q1 2025.